Antisense oligonucleotides for identifying drug targets and enhancing cancer therapies
作者： D. James Koropatnick , Randall W. Berg , Mark D. Vincent
DOI:
关键词:
摘要: The present invention provides antisense oligonucleotides useful for identifying drug targets cancer therapies and enhancing current therapies. of the are complementary to thymidylate synthase mRNA affect expression at least one other gene. For enhancement therapies, such can be used in conjunction with standard chemotherapeutic agents order target synthase, as well appropriate targets. methods constitute improved application a variety cancers.
lens.org参考文章(4)
Peter J Ferguson, Olga Collins, Nicholas M Dean, Janice DeMoor, Chen Sha-Li, Mark D Vincent, James Koropatnick, Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cells. British Journal of Pharmacology. ,vol. 127, pp. 1777- 1786 ,(1999) , 10.1038/SJ.BJP.0702728
T. Inomoto, T. Kitai, M. Ukikusa, K. Ino, H. Higashiyama, A. Arimoto, Y. Nakajima, T. Hanafusa, H. Awane, H. Kobayashi, Dihydropyrimidine dehydrogenase and thymidylate synthase in relation to 5-fluorouracil sensitivity of breast cancer European Journal of Cancer. ,vol. 35, ,(1999) , 10.1016/S0959-8049(99)81204-0
S. Hiroyasu, Clinical relevance of the concentrations of both pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer. Japanese Journal of Clinical Oncology. ,vol. 31, pp. 65- 68 ,(2001) , 10.1093/JJCO/HYE014
Nicholas M. Dean, Antisense oligonucleotide modulation of human thymidylate synthase expression ,(1998)